Search found 18 matches

I think most people who have followed Tysabri know that Dr. Steinman works for another, competitive company. Most "expert" opinions given on behalf of a particular drug by a doctor have the drug compa ...

You also have a choice of who you select to be your physician or specialist. My typically conservative and cautious neuro, who is currently TOUCH certified, had also given in to my eagerness to be pr ...

There is no doubt in my mind that Dr. Larry Steinman is one of many professional thought leaders in the field of MS research. However, lets take a closer look at his previous role in the development ...

Harry,

The conflicted and biased research study you refered to was ORIGINALLY and COINCIDENTALLY presented just prior to the Tysabri FDA AC meeting in March. It's old F.U.D which I think was spons ...

First of all, a clinically diagnosed, treatment naive MSer has too many infiltrating or cascading WBCs in their CSF. An AIDs patient has a severely degraded immune system and poor immune suveillance i ...

For information how you can support our worthy cause and join our spirit rally on March 7th please visit this website at:

http://mspatientsforchoice.org/index.htm

It's not about just any old, in ...

If a therapy or med is working for that patient it's all well and good. Too bad way too many of us veterans can't get that satisfaction. I am in a well connected and informed group of MSers who will g ...

I quit Betaseron in Oct2004 after almost 10 years of therapy in preparation to go on Tysabri earlier this year. Oddly enough, an exacerbation that had appearred in mid 2004 followed by more relapses l ...

MS patients didn't hear about PML until Tysabri came along. This drug is a powerful, immune system altering medication and it needs a lot more study done on it....far more than Biogen/Elan gave it pri ...

Harry, nice one. I wasn't trying to convince you of something you already knew. I was trying to tell you something new. I reworded my previous question into a statement. Now read it again and tell me ...

Comparing the data and endpoints with other mutually exclusive clinical trials is unscientific methodology.

Please show me where any of the ABCR drugs showed 28% SUSTAINED disease reversal by 100 ...

I intentionally quit Betaseron therapy in Oct 2004 in anticipation of starting Tysabri therapy as soon as it was commercially avialable after FDA approval.

When I received my first dose of Tysabri ...

Yep, the new drug was selling like hotcakes right out of the chute. I also was in full support of the suspension of the drug from commercial distribution and the Sentinel clinical study when the safet ...

Many of us Msers are already at 100% risk of further disability and disease progression. The CRABs are a dismal failure for many of us. And along comes a brand new drug that offers us some hope and th ...

I have to agree to disagree with you on one of your comments. The mechanism of action of natalizumab therapy comes much closer to mitigating the precursory inflammatory stage of MS than any of the exi ...